A perspective on the use of Pleurotus for the development of convenient fungi-made oral subunit vaccines
Review
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
This review provides an outlook of the medical applications of immunomodulatory compounds taken from Pleurotus and proposes this fungus as a convenient host for the development of innovative vaccines. Although some fungal species, such as Saccharomyces and Pichia, occupy a relevant position in the biopharmaceutical field, these systems are essentially limited to the production of conventional expensive vaccines. Formulations made with minimally processed biomass constitute the ideal approach for developing low cost vaccines, which are urgently needed by low-income populations. The use of edible fungi has not been explored for the production and delivery of low cost vaccines, despite these organisms%27 attractive features. These include the fact that edible biomass can be produced at low costs in a short period of time, its high biosynthetic capacity, its production of immunomodulatory compounds, and the availability of genetic transformation methods. Perspectives associated to this biotechnological application are identified and discussed. © 2014 Elsevier Ltd.
-
This review provides an outlook of the medical applications of immunomodulatory compounds taken from Pleurotus and proposes this fungus as a convenient host for the development of innovative vaccines. Although some fungal species, such as Saccharomyces and Pichia, occupy a relevant position in the biopharmaceutical field, these systems are essentially limited to the production of conventional expensive vaccines. Formulations made with minimally processed biomass constitute the ideal approach for developing low cost vaccines, which are urgently needed by low-income populations. The use of edible fungi has not been explored for the production and delivery of low cost vaccines, despite these organisms' attractive features. These include the fact that edible biomass can be produced at low costs in a short period of time, its high biosynthetic capacity, its production of immunomodulatory compounds, and the availability of genetic transformation methods. Perspectives associated to this biotechnological application are identified and discussed. © 2014 Elsevier Ltd.
publication date
funding provided via
published in
Research
keywords
-
Adjuvant; Fungi; Glucan; Mushrooms; Oral subunit vaccine; Production cost fungus vaccine; immunomodulating agent; subunit vaccine; edible vaccine; recombinant vaccine; subunit vaccine; biomass; drug delivery system; genetic engineering; genetic transformation; mushroom; nonhuman; Pleurotus ostreatus; protein glycosylation; Review; vaccine production; biotechnology; genetics; human; metabolism; pharmaceutics; Pleurotus; procedures; Biotechnology; Humans; Pleurotus; Technology, Pharmaceutical; Vaccines, Edible; Vaccines, Subunit; Vaccines, Synthetic
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue